BusinessaTyr Pharma to Present at Jefferies 2017 Global Healthcare ConferenceBy Nasdaq OMXMay 31, 2017, 1:09 PM UTC
BusinessaTyr Pharma to Present at Jefferies 2017 Global Healthcare ConferenceBy Nasdaq OMXMay 31, 2017, 1:09 PM UTC
BusinessaTyr Pharma Announces Presentations on Interstitial Lung Disease and the iMod.Fc Program at the American Thoracic Society 2017 International Conference and Will Host an Educational WebinarBy Nasdaq OMXMay 15, 2017, 12:03 PM UTC
BusinessaTyr Pharma Announces Presentations on Interstitial Lung Disease and the iMod.Fc Program at the American Thoracic Society 2017 International Conference and Will Host an Educational WebinarBy Nasdaq OMXMay 15, 2017, 12:03 PM UTC
BusinessaTyr Pharma Announces Presentations on Interstitial Lung Disease and the iMod.Fc Program at the American Thoracic Society 2017 International Conference and Will Host an Educational WebinarBy Nasdaq OMXMay 15, 2017, 12:03 PM UTC
BusinessaTyr Pharma Announces First Quarter 2017 Operating ResultsBy Nasdaq OMXMay 11, 2017, 8:06 PM UTC
BusinessaTyr Pharma Announces First Quarter 2017 Operating ResultsBy Nasdaq OMXMay 11, 2017, 8:06 PM UTC
BusinessaTyr Pharma Presents Analyses of Resolaris Phase 1b/2 Trial in Patients with Limb Girdle Muscular Dystrophy 2B and Facioscapulohumeral Muscular Dystrophy at the American Academy of Neurology 69th Annual MeetingBy Nasdaq OMXApr 24, 2017, 12:02 PM UTC
